Next-Gen analytics for mRNA and LNPs: when traditional methods fall short
Following the first mRNA-LNP based Covid-19 vaccines, a plethora of new modalities were invented that are directed to treating and preventing diseases in previously unimaginable ways. With these new modalities, both in the field of XNA and their encapsulating modalities (Lipid Nano Particles) standard methods fall short, lacking the resolution, specificity, and adaptability needed to...
